Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DOXAZOSIN vs DOXORUBICIN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DOXAZOSIN vs DOXORUBICIN: Safety Overview

Metric DOXAZOSIN DOXORUBICIN
Total FAERS Reports 4,741 82,754
Deaths Reported 256 15,653
Death Rate 5.4% 18.9%
Hospitalizations 2,065 28,630
Average Patient Age 67.2 yrs 50.5 yrs
% Female Patients 33.8% 53.9%
FDA Approval Date Apr 17, 2018 Approved Prior to Jan 1, 1982
Manufacturer A-S Medication Solutions Hikma Pharmaceuticals USA Inc.
Route ORAL INTRAVENOUS
Marketing Status Prescription Discontinued